Sequenom, Inc.
Clinical trials sponsored by Sequenom, Inc., explained in plain language.
-
New blood test could predict dangerous pregnancy condition earlier
Diagnosis Recruiting nowThis study aims to improve how doctors screen for preeclampsia, a serious condition that can harm both mother and baby. Researchers will collect blood samples from over 6,500 pregnant women between 11-14 weeks of pregnancy. They will then compare the test results with actual preg…
Sponsor: Sequenom, Inc. • Aim: Diagnosis
Last updated May 26, 2026 06:25 UTC
-
New blood test aims to reduce unnecessary prostate biopsies
Diagnosis Recruiting nowThis study is testing a blood test called Proclarix to see if it can better predict which men have aggressive prostate cancer. About 500 men scheduled for a prostate biopsy will give a blood sample before the procedure. The test results will be compared to the biopsy results to s…
Sponsor: Sequenom, Inc. • Aim: Diagnosis
Last updated May 08, 2026 12:00 UTC